Development and validation of a Delphi consensus-based questionnaire for the multidisciplinary management of type 2 inflammation-related diseases.

IF 3.3 Q2 ALLERGY
Frontiers in allergy Pub Date : 2025-04-03 eCollection Date: 2025-01-01 DOI:10.3389/falgy.2025.1543504
Francisco Javier Ortiz de Frutos, Carolina Cisneros, José Miguel Villacampa, Óscar Palomares, Ignacio Dávila
{"title":"Development and validation of a Delphi consensus-based questionnaire for the multidisciplinary management of type 2 inflammation-related diseases.","authors":"Francisco Javier Ortiz de Frutos, Carolina Cisneros, José Miguel Villacampa, Óscar Palomares, Ignacio Dávila","doi":"10.3389/falgy.2025.1543504","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to validate a 15-item screening questionnaire for the early detection of coexisting type 2 (T2) inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps (CRSwNP), among others.</p><p><strong>Methods: </strong>The questionnaire, designed through expert consensus by a scientific committee, underwent Delphi methodology for validation. A multidisciplinary panel of 19 clinicians from different specialties reviewed the questionnaire for clinical relevance, while 39 patients from different regions of Spain evaluated its comprehensibility.</p><p><strong>Results: </strong>The clinician panel reached a consensus on the relevance of 13 out of 15 items in the first round and agreed that a single positive response was sufficient to justify referral to the appropriate specialist. Two items were modified and validated in the second round. The patient panel unanimously agreed on the comprehensibility of the questionnaire in the first round. Linguistic variations were also ranked to ensure clarity across regions, further enhancing the validation of the tool.</p><p><strong>Conclusion: </strong>This validated questionnaire offers a practical tool for early detection of T2 inflammatory diseases. Its simplicity and comprehensibility, confirmed by clinicians and patients, make it suitable for use in various healthcare settings, supporting timely specialist referrals and improved patient care. Future studies will evaluate its effectiveness in real-world clinical practice.</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":"6 ","pages":"1543504"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003428/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2025.1543504","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to validate a 15-item screening questionnaire for the early detection of coexisting type 2 (T2) inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps (CRSwNP), among others.

Methods: The questionnaire, designed through expert consensus by a scientific committee, underwent Delphi methodology for validation. A multidisciplinary panel of 19 clinicians from different specialties reviewed the questionnaire for clinical relevance, while 39 patients from different regions of Spain evaluated its comprehensibility.

Results: The clinician panel reached a consensus on the relevance of 13 out of 15 items in the first round and agreed that a single positive response was sufficient to justify referral to the appropriate specialist. Two items were modified and validated in the second round. The patient panel unanimously agreed on the comprehensibility of the questionnaire in the first round. Linguistic variations were also ranked to ensure clarity across regions, further enhancing the validation of the tool.

Conclusion: This validated questionnaire offers a practical tool for early detection of T2 inflammatory diseases. Its simplicity and comprehensibility, confirmed by clinicians and patients, make it suitable for use in various healthcare settings, supporting timely specialist referrals and improved patient care. Future studies will evaluate its effectiveness in real-world clinical practice.

基于德尔菲共识的2型炎症相关疾病多学科管理问卷的开发和验证
目的:本研究旨在验证一份15项筛查问卷,用于早期发现共存的2型(T2)炎症性疾病,如哮喘、特应性皮炎、慢性鼻窦炎伴鼻息肉(CRSwNP)等。方法:问卷由科学委员会专家共识设计,采用德尔菲法进行验证。由来自不同专业的19名临床医生组成的多学科小组审查了问卷的临床相关性,而来自西班牙不同地区的39名患者评估了其可理解性。结果:临床医生小组就第一轮15个项目中的13个项目的相关性达成共识,并同意一个积极的回应足以证明转诊到适当的专家。在第二轮对两个项目进行了修改和验证。患者小组在第一轮中一致同意问卷的可理解性。语言差异也进行了排名,以确保不同地区的清晰度,进一步增强了该工具的有效性。结论:该问卷为早期发现T2炎性疾病提供了实用工具。经临床医生和患者确认,它的简单性和可理解性使其适合在各种医疗保健环境中使用,支持及时的专家转诊和改善患者护理。未来的研究将评估其在现实世界临床实践中的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信